In agreement, both DNMT3a and Plk1 were upregulated in patients with metastatic CRPC by comparing profiles between 22 PCa benign tissues and 32 metastatic CRPC tissues to PDX002286 data analysis. This evidence concerns the gene PLK1 and posterior cortical atrophy.